Clinical trials: Triple Branch
Orthodontic Appliance Complication
Effect of Moringa Oleifera Mouthwash
Improvement of oral hygiene maintenance is very important during fixed orthodontic appliance treatment to prevent the degenerative effects.
- Trial name
- NCT05191069
- Testing
- Moringa Oleifera Mouthwash
- Where
- Pakistan
- Volunteers
- 50 people
- Sponsor
- Riphah International University
Aortic Arch, Aortic Arch Aneurysm
Outcome of a Triple Inner Branched Aortic Arch Stentgraft. A Prospective, Multicenter Registry.
Outcome of a triple inner branched aortic arch stentgraft. A prospective, mulitcenter registry.
- Conditions
- Aortic Arch, Aortic Arch Aneurysm, Dissection of Aortic Arch, Triple Branch
- Trial name
- triple_branch (NCT05530304)
- Testing
- Triple inner branched arch stentgraft
- Where
- Germany
- Volunteers
- 30 people
- Sponsor
- University Hospital Muenster
HIV Infections With Multi Drug Resistant Virus
Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their cART and Have Dual- or Triple-class Antiretroviral Resistance
In the SHIELD study, the study sponsor seeks to assess safety, PK and antiviral activity for children and adolescents with dual or triple class resistance.
- Trial name
- NCT04648280
- Testing
- Fostemsavir
- Where
- 8 sites in United States, Brazil and 1 more
- Volunteers
- 60 people
- Sponsor
- PENTA Foundation
Radiology, Internship and Residency
Measuring AI Reliance Among Intern Doctors in Palestine
This study aims to enroll intern doctors and have them sit one of three identical radiology exams. The only difference between them is an AI-assistant.
- Conditions
- Radiology, Internship and Residency, AI (Artificial Intelligence)
- Trial name
- AI-RP (NCT07558746)
- Testing
- AI prompt (Correct), AI prompt (Incorrect)
- Where
- Palestinian Territories
- Volunteers
- 159 people, healthy volunteers welcome
- Sponsor
- Al-Quds University
HIV Infections
A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)
To determine the relative clinical efficacy of zidovudine ( AZT ) plus didanosine (ddI), AZT plus zalcitabine ( ddC ), AZT alternating monthly with ddI, and AZT/ddI plus nevirapine in HIV-infected patients with advanced disease.
- Trial name
- NCT00000781
- Testing
- Nevirapine, Zidovudine, Zalcitabine
- Where
- 96 sites in United States, Puerto Rico
- Volunteers
- 1,292 people
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
AML, IDH1 Mutation
Venetoclax in Combination With Ivosidenib and Azacitidine for Newly Diagnosed IDH1-Mutated AML
Venetoclax can bind to the BCL-2 protein, thereby initiating the apoptosis program and exerting anti-AML effects. The induction regimen combining venetoclax with hypomethylating agents (HMA) significantly improves the remission…
- Conditions
- AML, IDH1 Mutation, Treatment
- Trial name
- IDH1-AML-2024 (NCT06611839)
- Testing
- Ivosidenib, Venetoclax, Azacitidine
- Where
- China
- Volunteers
- 23 people
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
Resistance Training, Sports Nutrition
Effects of Three Carbohydrate Beverages on Resistance Training Performance
This randomized, triple-blinded, counterbalanced crossover trial compared three carbohydrate beverages that provided the same amount of carbohydrate (30 g) but differed in carbohydrate source: dextrose, maltodextrin, and highly…
- Conditions
- Resistance Training, Sports Nutrition, Dietary Carbohydrates
- Trial name
- NCT07874776
- Testing
- Dextrose, Maltodextrin, Highly Branched Cyclic Dextrin
- Where
- Turkey (Türkiye)
- Volunteers
- 38 people, healthy volunteers welcome
- Sponsor
- Istanbul Gelisim University
Uncomplicated Plasmodium Falciparum Malaria
Triple Artemisinin-based Combination Therapy for Delaying Drug Resistance Development - a Randomized Clinical Trial
Background: Artemisinin resistance has emerged in parts of Southeast Asia, and there are reports in Africa of reduced susceptibility of Plasmodium falciparum parasites against artemisinin-based combination therapy (ACT).
- Trial name
- 3ACT (NCT05764746)
- Testing
- Artemether-lumefantrine and Amodiaquine Drug Combination, Artemether-lumefantrine then Artesunate amodiaquine, Artemether-lumefantrine
- Where
- 2 sites in Tanzania
- Volunteers
- 384 people
- Sponsor
- Muhimbili University of Health and Allied Sciences